Novartis, FDA confirm shortage over for prostate cancer drug

By Becker's Hospital Review - Healthcare News in Becker's Hospital Review, Channels, Featured, ROOT, Static
October 26, 2023

The FDA declared the shortage resolved for Pluvicto, a prostate cancer drug made by Novartis.

Read the full post on Becker's Hospital Review - Healthcare News

Becker's Hospital Review - Healthcare News